Non-suppression of Testosterone in Patients with a Rising Prostate-specific Antigen Level Receiving Luteinising Hormone-releasing Hormone Analogues for Metastatic Prostate Cancer

Saved in:

Bibliographic Details
Published in:	Clinical oncology (Royal College of Radiologists (Great Britain)) Vol. 18; no. 7; pp. 571 - 572
Main Authors:	Koupparis, A.J., Tyrrell, C.
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01-09-2006
Subjects:	Antineoplastic Agents - pharmacology Gonadotropin-Releasing Hormone - administration & dosage Gonadotropin-Releasing Hormone - analogs & derivatives Humans Male Neoplasm Metastasis - drug therapy Neoplasm Metastasis - pathology Prostate-Specific Antigen - biosynthesis Prostate-Specific Antigen - metabolism Prostatic Neoplasms - drug therapy Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Testosterone - antagonists & inhibitors
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1
ISSN:	0936-6555 1433-2981
DOI:	10.1016/j.clon.2006.04.001